|Bid||6.02 x 2200|
|Ask||7.07 x 1200|
|Day's range||7.01 - 7.34|
|52-week range||4.28 - 10.05|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||N/A|
|Earnings date||06 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||13.14|
Investors need to pay close attention to CytomX Therapeutic (CTMX) stock based on the movements in the options market lately.
CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) shareholders will doubtless be very grateful to see the share price up 36% in...
Thank you for standing by and welcome to CytomX Therapeutics Third Quarter 2021 Financial Results Call. With me today are Dr. Sean McCarthy, CytomX's President, Chief Executive Officer and Chairman; and Carlos Campoy, Chief Financial Officer.